Kopf-Hals-Tumoren: Aktuelle Daten zur Therapie mit Amivantamab
Crossref DOI link: https://doi.org/10.1007/s00060-026-9588-y
Published Online: 2026-02-13
Published Print: 2026-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Facharztmagazine, Redaktion
Text and Data Mining valid from 2026-02-01
Version of Record valid from 2026-02-01
Article History
First Online: 13 February 2026